Skip to main content
Journal of the American Society of Nephrology : JASN logoLink to Journal of the American Society of Nephrology : JASN
letter
. 2022 Oct;33(10):1952–1953. doi: 10.1681/ASN.2022060687

Authors’ Reply: Understanding the Multiple Roles of Extracellular Histones in Mediating Endothelial Dysfunction

Lara Zafrani 1,2,, Marine Arnaud 1, Nuala Mooney 1
PMCID: PMC9528337  PMID: 35922134

We would like to thank Tinghang et al. for their interest in our manuscript and their constructive comments. In their letter, they underline information regarding the role of extracellular histones on endothelial cytotoxicity. Indeed, they refer to the work of Karki and coworkers1 that reported data from studies in pulmonary artery endothelial cells, which were similar to the data we have obtained in a human microvascular endothelial cell line and in primary human renal glomerular endothelial cells, i.e., the ability of histones H3 and H4 to induce an inflammatory response and to increase endothelial permeability and the implication of Toll-like receptor 4.

In keeping with our in vivo results showing an increase in peritubular endothelial permeability in mice with tumor lysis syndrome and mice injected with histones,2 they report that the histone subunits H3 and H4 cause endothelial barrier disruption and a decrease in vascular endothelial (VE)-cadherin expression in pulmonary endothelial cells. Disassembly of adherence junctions compromised by the integrity of the VE-cadherin adhesion complex has been described in many pathologic conditions associated with increased endothelial permeability. However, data on pulmonary endothelial cells should be interpreted with caution in the specific context of AKI due to the high degree of heterogeneity of vascular endothelial cells in different organs. Indeed, whereas the pulmonary endothelium is a continuous vascular endothelium, fenestrated endothelial cells are seated within the glomeruli and tubuli of the kidney. In human renal glomerular cells and human dermal microvascular cells, we did not observe any change in CD144 (VE-cadherin) staining after H3 stimulation. The discrepancy with the results mentioned by Tinghang et al.1,3 may be due to dissimilar expression of VE-cadherin according to endothelial cell subtypes and/or organs.4 Beyond the role of VE-cadherin, LPS-induced disruption of other tubular tight junction proteins, including zonula occludens-1, occludin, and claudins, via a Toll-like receptor 4–dependent mechanism, has also been involved in endotoxemic-mediated AKI.5,6 This could represent yet another promising pathway of investigation to decipher the mechanisms underpinning the increase of peritubular permeability induced by extracellular histones.

Overall, the published data mentioned by Tinghang et al. add further information to our results concerning the potential role of extracellular histones in endothelial permeability that may be involved in organ failure in various pathologic conditions, including tumor lysis syndrome.

Disclosures

L. Zafrani reports receiving research funding from Jazz Pharmaceuticals. All remaining authors have nothing to disclose.

Funding

None.

Footnotes

Published online ahead of print. Publication date available at www.jasn.org.

See related letters to the editor, “Understanding the Multiple Roles of Extracellular Histones in Mediating Endothelial Dysfunction,” on pages 1951–1952, and original article, “Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms,” in Vol. 33, Iss. 6, Pages 1154–1171.

Author Contributions

L. Zafrani wrote the original draft; and all authors reviewed and edited the manuscript.

References

  • 1.Karki P, Zhang C, Li Y, Promnares K, Birukov KG, Birukova AA: Toll‐like receptor 4 mediates histone subunit H3‐induced endothelial dysfunction in human lung endothelium. Presented at the annual Federation of American Societies for Experimental Biology 2022 meeting, Philadelphia, Pennsylvania, April 2–5, 2022
  • 2.Arnaud M, Loiselle M, Vaganay C, Pons S, Letavernier E, Demonchy J, et al. : Tumor lysis syndrome and AKI: Beyond crystal mechanisms. J Am Soc Nephrol 33: 1154–1171, 2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Biswas I, Panicker SR, Cai XS, Giri H, Rezaie AR: Extracellular histones bind vascular glycosaminoglycans and inhibit the anti-inflammatory function of antithrombin. Cell Physiol Biochem 55: 605–617, 2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Prandini M-H, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P: The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 24: 2992–3001, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nakano D, Kitada K, Wan N, Zhang Y, Wiig H, Wararat K, et al. : Lipopolysaccharide induces filtrate leakage from renal tubular lumina into the interstitial space via a proximal tubular Toll-like receptor 4-dependent pathway and limits sensitivity to fluid therapy in mice. Kidney Int 97: 904–912, 2020 [DOI] [PubMed] [Google Scholar]
  • 6.Eadon MT, Hack BK, Xu C, Ko B, Toback FG, Cunningham PN: Endotoxemia alters tight junction gene and protein expression in the kidney. Am J Physiol Renal Physiol 303: F821–F830, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the American Society of Nephrology : JASN are provided here courtesy of American Society of Nephrology

RESOURCES